Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Influenza
Biotech
Sanofi abandons attempt to develop mRNA seasonal flu vaccine
Fierce Biotech has learned that the French pharma has put its plans for an mRNA seasonal flu vaccine on ice.
James Waldron
Jan 29, 2026 10:26am
CEPI to fund Moderna's pandemic flu trial after HHS walked away
Dec 18, 2025 9:40am
Merck pays $9.2B for owner of flu antiviral J&J rejected
Nov 14, 2025 8:25am
Fierce Pharma
Cidara snares BARDA award to boost R&D, production of flu asset
Oct 3, 2025 10:10am
Federal mRNA vax grant cuts includes unrelated project
Aug 7, 2025 2:20pm
Moderna's flu/COVID vaccine hit by deprioritization, FDA delay
May 1, 2025 7:24am
